Affinity Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,941
Closed -$283K 198
2023
Q2
$283K Buy
+1,941
New +$264K 0.16% 172
2017
Q3
Sell
-18,581
Closed -$2.32M 184
2017
Q2
$2.32M Sell
18,581
-13,061
-41% -$1.55M 0.28% 76
2017
Q1
$3.75M Buy
31,642
+5,418
+21% +$614K 0.34% 75
2016
Q4
$2.63M Sell
26,224
-11,788
-31% -$1.26M 0.25% 98
2016
Q3
$4.8M Sell
38,012
-14,420
-28% -$1.78M 0.41% 73
2016
Q2
$6.13M Buy
+52,432
New +$5.93M 0.45% 78

Other funds holding ZBH

Affinity Investment Advisors's ZBH Position: Q3 2023 in Review

Affinity Investment Advisors sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,941 shares — an estimated $283K sold.

Affinity Investment Advisors first reported a position in ZBH in Q2 2016 and held it in 6 quarters. The position peaked at $6.13M in Q2 2016. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Affinity Investment Advisors reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Affinity Investment Advisors sold 1,941 Zimmer Biomet shares in Q3 2023, an estimated $283K.
  • Affinity Investment Advisors first reported a position in Zimmer Biomet in Q2 2016 and held it in 6 quarters.
  • Affinity Investment Advisors's Zimmer Biomet position peaked at $6.13M in Q2 2016.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Affinity Investment Advisors's 13F filing for Q3 2023, filed 26 Oct 2023.